D5B is a DBCO-modified small molecule that selectively inhibits and degrades PD-L1, demonstrating antitumor activity by disrupting the PD-1/PD-L1 interaction. It effectively reduces PD-L1 levels in vitro in cell lines such as 4T1 and B16-F10, supporting its application in immuno-oncology research.
Molecular Weight:
983.15
Formula:
C58H66N2O12
Target:
PD-1/PD-L1
* VAT and and shipping costs not included. Errors and price changes excepted